Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

288.94
Delayed Data
As of Feb 17
 -1.19 / -0.41%
Today’s Change
205.42
Today|||52-Week Range
307.33
+10.62%
Year-to-Date
3 Top Drug Stocks That Can Be Purchased on the Cheap This Winter
Feb 20 / MotleyFool.com - Paid Partner Content
Drug Stocks Earnings Slated for Feb 14: INCY, PRTA & More
Feb 13 / Zacks.com - Paid Partner Content
Could Celgene Have Another Billion-Dollar Blockbuster on Its Hands?
Feb 19 / MotleyFool.com - Paid Partner Content
A Potential $20 Billion Indication? 2 Must-Have Biotechs Taking on Alzheimer's Diseas...
Feb 11 / MotleyFool.com - Paid Partner Content
Celgene Multiple Sclerosis Pill Succeeds in First Late-Stage Clinical Trial
Feb 17 / TheStreet.com - Paid Partner Content
Is Biogen a Risky Stock?
Feb 10 / MotleyFool.com - Paid Partner Content
Alzheimer's Market Suffers Yet Another Blow with Merck Drug Setback
Feb 16 / Zacks.com - Paid Partner Content
Biotech ETFs Powered by Q4 Earnings
Feb 10 / Zacks.com - Paid Partner Content
Another Potential Alzheimer's Disease Treatment Bites the Dust: What's Next?
Feb 15 / MotleyFool.com - Paid Partner Content
What's Behind Bioverativ's Spin-Out, and Should You Buy?
Feb 08 / MotleyFool.com - Paid Partner Content
Sector Gamma As Buys Vertex Pharmaceuticals, Shire PLC, United Therapeutics, Sells Bi...
Feb 15 / GuruFocus News - Paid Partner Content
Biotech Stock Roundup: Amgen, Gilead Report 4Q Results, ARIAD Seeks EU Nod for Brigat...
Feb 08 / Zacks.com - Paid Partner Content
Two Sigma Investments Llc Buys Micron Technology, Medtronic PLC, Biogen, Sells Marrio...
Feb 15 / GuruFocus News - Paid Partner Content
In an Ironic Twist, Generics Take Aim at Teva Pharmaceutical
Feb 07 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Regeneron's Praluent to Remain on Market for Now, GILD Present...
Feb 15 / Zacks.com - Paid Partner Content